Abstract:Prostate cancer (PC), which responds well to androgen ablation initially, invariably progresses to treatment resistance. The so-called androgen-independent PC is also a concern, since there is no effective therapy so far. Nkx3.1 is a putative prostate tumor suppressor that is expressed exclusively in the prostate under the regulation of androgen, and p27(KIP1) functions as a cell proliferation inhibitor and apoptosis trigger by disrupting the cyclin-dependent kinase (CDK)-cyclin complex. Lack of expressions of Nkx3.1 and/or p27(KIP1) have been detected in most advanced PC and is associated with poor clinical progression. Here, we show that endogenous expressions of both Nkx3.1 and p27(KIP1) are lost in the androgen-independent PC3 PC cells, while remaining intact in LNCaP PC cells, which contain functional androgen receptor (AR) and are hormone-responsive. Ectopic restoration of either Nkx3.1 or p27(KIP1) in PC3 cells results in reduced cell proliferation, and increased cell death. Both effects are synergistically enhanced when the two molecules are coexpressed. p27(KIP1) overexpression in PC3 results in increased cell population ceased at the G0/G1 phase, and this cell-cycle-arresting effect is significantly enhanced by the coexpression of Nkx3.1. Flow cytometry further revealed that Nkx3.1 and p27(KIP1) also cooperatively render more PC3 cells undergoing apoptosis. Consistently, the coexpression of Nkx3.1 and p27(KIP1) leads to the decreased expression of Bcl-2 oncogene and a concomitantly upregulated Bax expression. It also activates caspase 3 and leads to increased cleavage of PARP. Our findings thus reveal the crucial relevance of the combined antiproliferative and proapoptotic activities of Nkx3.1 and p27(KIP1) in androgen-independent PC cells, and further suggest that a combined, rather than single gene manipulation may be of clinical value for hormone-refractory PC.

Molecular Mechanism for Downregulation and Mislocalization of P27kip1 in Tumor Cell

Protein Profiling: a Possible Molecular Mechanism to Mislocalization and Down-Expression of P27(kip1) in Tumor Cells.

Expression of P27 is Associated with Bax Expression and Spontaneous Apoptosis in Oral and Oropharyngeal Carcinoma

The Cross-talk Between p27~(kip1) and Its Interacting Molecules in Breast Cancer Cells

Expression of Protein P27 is Associated with Progression and Prognosis in Laryngeal Cancer

A crosstalk imbalance between p27(Kip1) and its interacting molecules enhances breast carcinogenesis.

Nkx3.1 and P27kip1cooperate in Proliferation Inhibition and Apoptosis Induction in Human Androgen–Independent Prostate Cancer Cells

Regulation of P27 Gene Expression and Its Role in Tumor Generation

[Expression and Clinical Significance of Ser10 Phosphorylated P27(kip1) Protein in Human Breast Carcinoma].

Prognostic Significance of Cytoplasmic P27 Expression in Human Melanoma

Cytoplasmic p27 is a novel prognostic biomarker and oncogenic protein for nasopharyngeal carcinoma.

Effect of P27(Kip1) on Cell Cycle and Apoptosis in Gastric Cancer Cells

P27kip1 and Ser10-phosphorylated P27kip1 in Breast Cancer: Clinical Significance and Expression

A Novel Cycline/cyclina-Cdk Inhibitor Targets P27(kip1) Degradation, Cell Cycle Progression and Cell Survival: Implications in Cancer Therapy.

Regulation of P27kip1 Phosphorylation and G1 Cell Cycle Progression by Protein Phosphatase PPM1G.

[Expression of Cyclin D1 and P27kip1 in Renal Cell Carcinoma and Its Significance].

[Prognostic Significance of Cyclin-Dependent Kinase Inhibitor P27kip1 Expression in Human Breast Cancer].

Over-expression of P27~(kip1) Threonine Residue 187 Mutant Type Gene Induces G_(0) Phase Arrest in HepG_(2) Cell Lines

Mutations of Phosphorylation Sites Ser10 and Thr187 of P27kip1 Abolish Cytoplasmic Redistribution but Do Not Abrogate G0/1 Phase Arrest in the HepG2 Cell Line

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

Expression of P27kip1 in resectable pancreatic carcinoma and its clinical significance